Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449408 · ClinicalTrials.gov registry record
Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World
A clinical trial of Overweight, Obesity, Small for Gestational Age, Prematurity, sponsored by Duke University.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT02449408: Completed study of Overweight, Obesity, Small for Gestational Age, Prematurity, sponsored by Duke University.
NCT02449408 is a study of Overweight, Obesity, Small for Gestational Age, Prematurity that has completed, run by Duke University. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02449408, a study of Overweight, Obesity, Small for Gestational Age, Prematurity, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the accuracy of a new device that may be used for the evaluation and management of malnourished infants and children. The device will measure the levels of two hormones made by fat tissue: leptin and adiponectin.
Primary Outcome
The 2-D diffusion POCT will be validated against commercial ELISA assays, run in the Duke Molecular Physiology Institute laboratory, using recombinant human leptin and high molecular weight adiponectin from blood samples. Dose-response curves will be generated using analyte-spiked buffer. The dose-response data from 20 separate dose-response dilutions will be fit with the five-parameter logistic (5-PL) curve. The coefficients of variation (inter and intra-assay) for standard ELISAs for leptin an
Conditions Studied
Interventions
- OTHER Measurement of leptin and adiponectin obtained through blood sampling via venipuncture or finger/heelstick using novel screening tool
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-05 |
What the finished NCT02449408 record still lists
NCT02449408 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 1 condition, with Overweight, Obesity, Small for Gestational Age, Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Measurement of leptin and adiponectin obtained through blood sampling via venipuncture or finger/heelstick using novel screening tool is the first listed.
NCT02449408 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02449408 about?
NCT02449408 is a clinical study titled "Novel Screening Tools For the Evaluation and Management of Malnourished Children in the Developing World". The purpose of this study is to evaluate the accuracy of a new device that may be used for the evaluation and management of malnourished infants and children. The device will measure the levels of two hormones made by fat tissue: leptin and adiponectin.
What is the current status of trial NCT02449408?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-05. Estimated completion is 2016-05.
What conditions does trial NCT02449408 study?
This clinical trial studies the following conditions: Overweight, Obesity, Small for Gestational Age, Prematurity.
What interventions are being tested in trial NCT02449408?
The interventions under investigation include: Measurement of leptin and adiponectin obtained through blood sampling via venipuncture or finger/heelstick using novel screening tool (OTHER).
Who is sponsoring clinical trial NCT02449408?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02449408 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia